Free Trial
NASDAQ:AMED

Amedisys Q3 2024 Earnings Report

Amedisys EPS Results

Actual EPS
$1.00
Consensus EPS
$1.19
Beat/Miss
Missed by -$0.19
One Year Ago EPS
$0.98

Amedisys Revenue Results

Actual Revenue
$587.67 million
Expected Revenue
$586.75 million
Beat/Miss
Beat by +$920.00 thousand
YoY Revenue Growth
+5.70%

Amedisys Announcement Details

Quarter
Q3 2024
Time
After Market Closes
Conference Call Date
Thursday, November 7, 2024
Conference Call Time
8:00AM ET

Amedisys Earnings Headlines

Musk's shopping list: batteries ✓ solar ✓ data ✓ power ___
Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity for $2.6 billion and Twitter for $44 billion. Now one small company makes the equipment his Colossus supercomputer - a million GPUs consuming nearly $1 billion a month in power - cannot run without. Analyst Dylan Jovine has identified the name and ticker. For investors who own shares before a potential move, the math could be significant.tc pixel
See More Amedisys Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Amedisys? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Amedisys and other key companies, straight to your email.

About Amedisys

Amedisys (NASDAQ:AMED) is a leading provider of home health, hospice and personal care services in the United States. Through its network of local care centers, the company delivers skilled nursing, physical and occupational therapies, medical social work, home health aides and related clinical support to patients in their homes. Its hospice division offers comprehensive end-of-life care, including pain management, counseling and bereavement support, designed to meet the physical, emotional and spiritual needs of terminally ill patients and their families.

The company operates under three primary service lines. Its home health segment focuses on post-acute care and chronic disease management, leveraging interdisciplinary teams to support recovery and independence. The hospice segment provides individualized care plans and around-the-clock clinical oversight, aiming to maintain patient comfort and dignity. Amedisys also offers personal care services, which include non-medical assistance with daily living activities such as bathing, dressing and meal preparation, to help clients remain safely in their homes.

Headquartered in Baton Rouge, Louisiana, Amedisys serves communities across more than 30 states and the District of Columbia. The company’s geographically diverse footprint allows it to tailor care solutions to urban, suburban and rural populations alike, often collaborating with hospitals, physician groups and payers to enhance care transitions and reduce avoidable hospital readmissions. Amedisys has pursued strategic growth through the development of new care centers and selective acquisitions aimed at expanding its service offerings and market reach.

Founded in 1982, Amedisys has grown from a regional home health provider into one of the nation’s largest post-acute care companies. The organization is led by President and Chief Executive Officer Paul F. Kusserow, who has overseen initiatives to integrate digital health tools, streamline clinical workflows and strengthen patient engagement. Under his leadership, the company has continued to focus on improving quality outcomes, enhancing caregiver support and driving operational efficiencies.

View Amedisys Profile